Brief: Targovax Enters Collaboration With Oblique

Circio Holding ASA

29/06/2020 06:08

June 29 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND OBLIQUE ENTER COLLABORATION TO TARGET MUTANT
RAS
CANCERS BY
    * TARGOVAX AND OBLIQUE WILL JOINTLY EXPLORE FEASIBILITY AND
ANTI-CANCER POTENTIAL OF MERGING THEIR ONCOS AND ABIPROT
TECHNOLOGY PLATFORMS
    * ONCOS WILL BE USED TO DELIVER ABIPROT ANTIBODIES AGAINST
HARD-TO-REACH TARGETS SUCH AS MUTANT RAS

Source text for Eikon:  ID:nObizSKx5a 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))